ArticleJapanese journal of radiology2026
Time-dependent diffusion-weighted imaging assessment of tumor grading and isocitrate dehydrogenase genotypes in adult-type diffuse gliomas.
Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
backgroundThis study aimed to investigate the usefulness of time-dependent diffusion magnetic resonance imaging (MRI) parameters compared with the conventional apparent diffusion coefficient (ADC) in distinguishing tumor grade and isocitrate dehydrogenase (IDH) genotypes of adult-type diffuse gliomas.
methodsThis retrospective study included 102 patients with adult-type diffuse gliomas. ADC maps obtained using diffusion-weighted imaging at short (7.1 ms) and long (44.5 ms) diffusion times (ADC7.1ms and ADC44.5ms) and maps of ADC changes (cADC) and relative ADC changes (rcADC) between the two diffusion times were generated. The mean, 5th, and 95th percentile values of each parameter were compared between low-grade (LGGs) and high-grade gliomas (HGGs) and between IDH-mutant and IDH-wildtype gliomas. The discriminative performance was assessed using receiver operating characteristic (ROC) analysis, and correlation with Ki-67 labeling index (Ki-67LI) was assessed using Spearman's rank correlation. Multivariable logistic regression analyses were conducted to predict HGGs and IDH-wildtype gliomas.
resultsIn HGGs, the mean and 5th percentile values of ADC44.5ms and ADC7.1ms were significantly lower, whereas cADC and rcADC indices were significantly higher than those in LGGs. Performance of the mean rcADC (area under the ROC curve: 0.925; 95% confidence interval: 0.855-0.967) was significantly better than any index of conventional ADCs for tumor grade classification. The mean rcADC demonstrated the strongest correlation with Ki-67LI (ρ = 0.542, p < 0.0001). Moreover, the 95th percentile of rcADC was an independent predictor of IDH-wildtype gliomas after adjustment for age and sex, was useful for distinguishing IDH-wildtype from IDH-mutant gliomas
conclusionsThe mean rcADC showed the strongest correlation with the Ki-67 LI and achieved better diagnostic performance than conventional PGSE-based ADC for differentiating LGGs from HGGs. In multivariable analyses, the mean and 95th percentile of rcADC were identified as independent predictors of HGGs and IDH-wildtype gliomas, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.